Triple

T23186850
Position Surface form Disambiguated ID Type / Status
Subject VelocImmune technology E579613 entity
Predicate relatedTo P37 FINISHED
Object VelociGene NE NERFINISHED

How this triple was built (3 steps)

Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.

NER Named-entity recognition gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: VelociGene | Statement: [VelocImmune technology, relatedTo, VelociGene]
NED1 Entity disambiguation (via context triple) gpt-5-mini-2025-08-07
Target entity: VelociGene
Context triple: [VelocImmune technology, relatedTo, VelociGene]
  • A. Visium
    Visium is a processor architecture supported by the GNU Assembler within the GNU Binutils toolchain.
  • B. Edico Genome
    Edico Genome was a biotechnology company specializing in high-speed genomic data analysis through its DRAGEN bio-IT platform and FPGA-based acceleration technology.
  • C. Ion Torrent
    Ion Torrent is a DNA sequencing technology platform known for its semiconductor-based sequencing method that detects hydrogen ions released during nucleotide incorporation.
  • D. Genex
    Genex is an airline that uses Minsk National Airport as a primary base of operations for its flight network.
  • E. LightCycler
    LightCycler is a real-time PCR instrument platform developed by Roche Diagnostics for rapid and quantitative analysis of nucleic acids in molecular biology and clinical diagnostics.
  • F. None of above. chosen
  • G. Unsure - the case is ambiguous/there is not enough information to decide.
NED2 Entity disambiguation (via description) gpt-5-mini-2025-08-07
Target entity: VelociGene
Target entity description: VelociGene is a high-throughput genetic engineering platform developed by Regeneron to precisely modify mouse and human genes for functional genomics and drug discovery research.
  • A. Visium
    Visium is a processor architecture supported by the GNU Assembler within the GNU Binutils toolchain.
  • B. Edico Genome
    Edico Genome was a biotechnology company specializing in high-speed genomic data analysis through its DRAGEN bio-IT platform and FPGA-based acceleration technology.
  • C. Ion Torrent
    Ion Torrent is a DNA sequencing technology platform known for its semiconductor-based sequencing method that detects hydrogen ions released during nucleotide incorporation.
  • D. Genex
    Genex is an airline that uses Minsk National Airport as a primary base of operations for its flight network.
  • E. LightCycler
    LightCycler is a real-time PCR instrument platform developed by Roche Diagnostics for rapid and quantitative analysis of nucleic acids in molecular biology and clinical diagnostics.
  • F. None of above. chosen

Provenance (2 batches)

The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.

Step Stage Batch ID Status When
creating Elicitation batch_69e245ff8000819090d12008805315b7 completed April 17, 2026, 2:38 p.m.
NER Named-entity recognition batch_69f18fd3aaa08190b9cf7afe4ee5a38d completed April 29, 2026, 4:57 a.m.
Created at: April 17, 2026, 4:05 p.m.